Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
CDNA
CDNA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CDNA News
CareDx to Host Investor Webcast on February 12
Feb 03 2026
Newsfilter
CareDx CEO Sells Nearly 20,000 Shares in Open Market Transactions
Feb 01 2026
Fool
CareDx CEO Sells Shares, Reduces Holdings by 3.16%
Feb 01 2026
NASDAQ.COM
CareDx CEO Sells Nearly 20,000 Shares in Open Market Transactions
Jan 30 2026
Fool
CareDx (CDNA) Reports Q4 Revenue of $108 Million, Up 25% YoY
Jan 12 2026
NASDAQ.COM
Earnings Warning Season is Here: Strategies to Benefit from Others' Struggles.
Dec 31 2025
Barron's
CareDx Awards 39 Employees 80,425 RSUs as Inducement Grants
Dec 26 2025
Businesswire
CareDx Grants 39 Employees 80,425 RSUs Under 2025 Inducement Plan
Dec 26 2025
Newsfilter
CareDx (CDNA): Reevaluating Valuation Following a Significant Short-Term Surge in Share Price
Dec 14 2025
Yahoo Finance
Wall Street Analysts Predict 28.02% Surge for CareDx (CDNA): Trading Strategies Explained
Nov 27 2025
NASDAQ.COM
Insights from Three Analysts on CareDx
Nov 06 2025
Benzinga
BTIG Reaffirms Buy Rating on CareDx, Increases Price Target to $25
Nov 06 2025
Benzinga
Post-Q3 Results: VCYT, RIGL, NPCE, CDNA, and FBLG Experience Significant After-Hours Gains
Nov 05 2025
NASDAQ.COM
CareDx (CDNA) Exceeds Expectations for Q3 Earnings and Revenue
Nov 05 2025
NASDAQ.COM
CareDx Names Jeffrey Teuteberg as Chief Medical Officer
Oct 27 2025
NASDAQ.COM
Projected Target Price for XBI by Analyst: $142
Sep 15 2025
NASDAQ.COM
Show More News